Compile Data Set for Download or QSAR
Report error Found 68 Enz. Inhib. hit(s) with all data for entry = 10238
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193014(CHEMBL3942643 | US11155556, No. 9)
Affinity DataIC50: 2nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193032(CHEMBL3979343 | US11155556, No. 2)
Affinity DataIC50: 2nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase A(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193017(CHEMBL3904942 | US11155556, No. 17)
Affinity DataIC50: 2nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193031(CHEMBL3959351 | US11155556, No. 12)
Affinity DataIC50: 2nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

LigandPNGBDBM50193032(CHEMBL3979343 | US11155556, No. 2)
Affinity DataIC50: 3nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

LigandPNGBDBM50193017(CHEMBL3904942 | US11155556, No. 17)
Affinity DataIC50: 4nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193017(CHEMBL3904942 | US11155556, No. 17)
Affinity DataIC50: 4nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193017(CHEMBL3904942 | US11155556, No. 17)
Affinity DataIC50: 4nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193030(CHEMBL3950648 | US11155556, No. 14)
Affinity DataIC50: 4nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase A(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50337135(CHEMBL1673047 | Benzo[e]pyrimido[5,4-b][1,4]diazep...)
Affinity DataIC50: 4.80nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

LigandPNGBDBM50193031(CHEMBL3959351 | US11155556, No. 12)
Affinity DataIC50: 7nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

LigandPNGBDBM50193014(CHEMBL3942643 | US11155556, No. 9)
Affinity DataIC50: 11nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50337135(CHEMBL1673047 | Benzo[e]pyrimido[5,4-b][1,4]diazep...)
Affinity DataIC50: 13.3nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

LigandPNGBDBM50337135(CHEMBL1673047 | Benzo[e]pyrimido[5,4-b][1,4]diazep...)
Affinity DataIC50: 14.5nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

LigandPNGBDBM50193023(CHEMBL3898901 | US11155556, No. 5)
Affinity DataIC50: 15nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193032(CHEMBL3979343 | US11155556, No. 2)
Affinity DataIC50: 16nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase A(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193030(CHEMBL3950648 | US11155556, No. 14)
Affinity DataIC50: 16nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193016(CHEMBL3889977 | US11155556, No. 3)
Affinity DataIC50: 20nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

LigandPNGBDBM50193030(CHEMBL3950648 | US11155556, No. 14)
Affinity DataIC50: 20nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase A(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193032(CHEMBL3979343 | US11155556, No. 2)
Affinity DataIC50: 23nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193023(CHEMBL3898901 | US11155556, No. 5)
Affinity DataIC50: 29.3nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193030(CHEMBL3950648 | US11155556, No. 14)
Affinity DataIC50: 30nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193020(CHEMBL3907932 | US11155556, No. 7)
Affinity DataIC50: 39nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193021(CHEMBL3922919 | US11155556, No. 13)
Affinity DataIC50: 41nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

LigandPNGBDBM50193015(CHEMBL3918001 | US11155556, No. 4)
Affinity DataIC50: 48.6nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase A(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193012(CHEMBL3926951 | US11155556, No. 6)
Affinity DataIC50: 49nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50337135(CHEMBL1673047 | Benzo[e]pyrimido[5,4-b][1,4]diazep...)
Affinity DataIC50: 49nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193018(CHEMBL3986648 | US11155556, No. 10)
Affinity DataIC50: 50.7nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

LigandPNGBDBM50193032(CHEMBL3979343 | US11155556, No. 2)
Affinity DataIC50: 53nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

LigandPNGBDBM50193031(CHEMBL3959351 | US11155556, No. 12)
Affinity DataIC50: 55nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

LigandPNGBDBM50193021(CHEMBL3922919 | US11155556, No. 13)
Affinity DataIC50: 58nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase A(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193032(CHEMBL3979343 | US11155556, No. 2)
Affinity DataIC50: 59nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

LigandPNGBDBM50193014(CHEMBL3942643 | US11155556, No. 9)
Affinity DataIC50: 70nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193029(CHEMBL3913941 | US11155556, No. 15)
Affinity DataIC50: 75.9nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193012(CHEMBL3926951 | US11155556, No. 6)
Affinity DataIC50: 80nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193012(CHEMBL3926951 | US11155556, No. 6)
Affinity DataIC50: 96nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

LigandPNGBDBM50193023(CHEMBL3898901 | US11155556, No. 5)
Affinity DataIC50: 104nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

LigandPNGBDBM50193029(CHEMBL3913941 | US11155556, No. 15)
Affinity DataIC50: 108nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase A(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193014(CHEMBL3942643 | US11155556, No. 9)
Affinity DataIC50: 110nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

LigandPNGBDBM50193032(CHEMBL3979343 | US11155556, No. 2)
Affinity DataIC50: 112nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193014(CHEMBL3942643 | US11155556, No. 9)
Affinity DataIC50: 117nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193032(CHEMBL3979343 | US11155556, No. 2)
Affinity DataIC50: 120nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

LigandPNGBDBM50193016(CHEMBL3889977 | US11155556, No. 3)
Affinity DataIC50: 122nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193015(CHEMBL3918001 | US11155556, No. 4)
Affinity DataIC50: 123nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193020(CHEMBL3907932 | US11155556, No. 7)
Affinity DataIC50: 130nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase A(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193031(CHEMBL3959351 | US11155556, No. 12)
Affinity DataIC50: 151nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193031(CHEMBL3959351 | US11155556, No. 12)
Affinity DataIC50: 152nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase A(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193020(CHEMBL3907932 | US11155556, No. 7)
Affinity DataIC50: 188nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193032(CHEMBL3979343 | US11155556, No. 2)
Affinity DataIC50: 231nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

TargetAurora kinase A(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50193023(CHEMBL3898901 | US11155556, No. 5)
Affinity DataIC50: 272nMAssay Description:The enzymatic activities against PI3K-α, PI3K-β, PI3K-γ and PI3K-δ were tested in ADAPTA assays. Activity against AURKB and AURKB...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 68 total ) | Next | Last >>
Jump to: